World Healthcare Fund (THW) has a high 11.7% dividend yield, ideal for income generation and positioned for future growth in ...

Caregiving is a full time job with its own ups and downs. This holiday season, one West Michigan author hopes to offer a bit ...

For many across the Middle East, the Israel-Hezbollah ceasefire came as a relief: the first major sign of progress in the ...

France said Wednesday that it 'intends to continue to work in close collaboration' with Israeli Prime Minister Benjamin Netanyahu despite an arrest warrant issued for him by the world’s top war crimes ...

NTPC Green Energy Shares Rise in Debut After More Than $1 Billion IPO The renewable-energy arm of state-controlled power company NTPC raised 100 billion rupees in the ... declines across its namesake ...

In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body ...

The Medicare insurance program now pays for drugs like Novo Nordisk A/S’s Ozempic and Eli Lilly & Co ... Coverage for obesity ...

The plans from the Department of Health and Human Services come on the heels of criticism Ozempic and other weight loss medications received by RFK Jr.

The good news is that HHS recognizes that vitally important anti-obesity medicines like Wegovy and Zepbound should be made available to all Americans, regardless of income. The bad news is that unless ...

Shares in Amgen fell by double digits Tuesday on results for the company’s MariTide shot, which is viewed as a potential rival to Wegovy and Zepbound.

A highly anticipated obesity-drug candidate from biotech Amgen helped patients shed a significant amount of weight in a ...

The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were mostly higher early Tuesday after the Biden administration proposed a rule that would allow Medicare ...